Annual Securities Report — FY2025
What SANTEN PHARMACEUTICAL CO.,LTD. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-18View the original on EDINET
How much it says
73Detailed
What moved here
27named for the first time
Its own wording
70terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
SANTEN PHARMACEUTICAL CO.,LTD. filed its Securities Report for the fiscal year ending March 2026 under the ordinary filing format, disclosing performance for the consolidated fiscal year, including revenue and profit, the status of funding and capital expenditures, R&D progress, and risk management. No significant events, including business combinations, were reported, with the filing stating that there were no applicable matters. Overall, the filing primarily organizes routine year-end reporting.
Komori's summary of this document, not the document's own words.73Detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
96
Very detailed
70
Detailed
44
Thin
62
Detailed
0
Almost nothing
100
Very detailed
68
Detailed
100
Very detailed
100
Very detailed
100
Very detailed
73
Detailed
R&D spend262億円Money spent making new things.
Cash left overNot disclosedThis document does not carry the figure.
Spent on equipment73億円Plants, machines — things meant to last.
Employees3,968Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.